These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18551309)

  • 21. Role of FUS-CHOP in Myxoid Liposarcoma via miR-486/CDK4 Axis.
    Wu H; Xia L; Xu H
    Biochem Genet; 2022 Jun; 60(3):1095-1106. PubMed ID: 34792704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Identification of genes over-expressed in myxoid/round cell liposarcoma. DNA microarray analysis and immunohistochemical correlation].
    Lanckohr C; Kasprzynski A; Klein-Hitpass L; Homann HH; Lehnhardt M; Müller O; Kuhnen C; Herter P
    Pathologe; 2010 Feb; 31(1):60-6. PubMed ID: 19823827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Well-differentiated/dedifferentiated liposarcoma associated with myxoid-like morphology: a clinicopathological and molecular genetic characteristics analysis of 34 cases].
    Xue S; Liu QY; Gou XN; Zhao YW; Cheng Q; Kong LF
    Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):168-173. PubMed ID: 38281785
    [No Abstract]   [Full Text] [Related]  

  • 24. Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma With Features Mimicking Spindle Cell Lipoma.
    Jebastin JAS; Perry KD; Chitale DA; Mott MP; Sanchez J; Fritchie KJ; Palanisamy N; Williamson SR
    Int J Surg Pathol; 2020 May; 28(3):336-340. PubMed ID: 31672072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Myxiod pleomorphic liposarcoma: a clinicopathological and molecular genetic analysis of six cases].
    Zheng XC; Huang HJ; You J; Lin XY; Chen DR; Zhong D
    Zhonghua Bing Li Xue Za Zhi; 2022 Aug; 51(8):738-742. PubMed ID: 35922164
    [No Abstract]   [Full Text] [Related]  

  • 26. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.
    Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F
    Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical spindle cell lipoma: a clinicopathologic, immunohistochemical, and molecular study emphasizing its relationship to classical spindle cell lipoma.
    Creytens D; van Gorp J; Savola S; Ferdinande L; Mentzel T; Libbrecht L
    Virchows Arch; 2014 Jul; 465(1):97-108. PubMed ID: 24659226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lipoma and atypical lipomatous tumor within the same neoplasia: Evidence for a continuous transition].
    Kuhnen C; Mentzel T; Lehnhardt M; Homann HH; Sciot R; Debiec-Rychter M
    Pathologe; 2010 Mar; 31(2):129-34. PubMed ID: 20063101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paratesticular myxoid/round cell liposarcoma harboring type 3 DDIT3-FUS fusion gene: report of a very rare case.
    Zozumi M; Nakai M; Matsuda I; Hao H; Tsukamoto Y; Shiraishi Y; Nojima M; Yamamoto S; Hirota S
    Pathol Res Pract; 2013 Feb; 209(2):124-7. PubMed ID: 23276404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic Accuracy of Immunohistochemical Expression of p16, MDM2, and CDK4 in Well-Differentiated and De-Differentiated Liposarcoma in MDM2 Fluorescent in situ Hybridisation Confirmed Cases.
    Aslam A; Din HU; Qadir A; Aslam U; Humayoun S; Ahmed W
    J Coll Physicians Surg Pak; 2024 Sep; 34(9):1051-1055. PubMed ID: 39262004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MDM2 and CDK4 Immunohistochemistry: Should It Be Used in Problematic Differentiated Lipomatous Tumors?: A New Perspective.
    Clay MR; Martinez AP; Weiss SW; Edgar MA
    Am J Surg Pathol; 2016 Dec; 40(12):1647-1652. PubMed ID: 27508976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of TLS/FUS-CHOP fusion transcripts in a case of oral liposarcoma.
    Rivero ER; Mesquita RA; de Sousa SC; Nunes FD
    Ann Diagn Pathol; 2006 Feb; 10(1):36-8. PubMed ID: 16414544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DDIT3 gene break-apart as a molecular marker for diagnosis of myxoid liposarcoma--assay validation and clinical experience.
    Narendra S; Valente A; Tull J; Zhang S
    Diagn Mol Pathol; 2011 Dec; 20(4):218-24. PubMed ID: 22089349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myxoid pleomorphic liposarcoma-a clinicopathologic, immunohistochemical, molecular genetic and epigenetic study of 12 cases, suggesting a possible relationship with conventional pleomorphic liposarcoma.
    Creytens D; Folpe AL; Koelsche C; Mentzel T; Ferdinande L; van Gorp JM; Van der Linden M; Raman L; Menten B; Fritchie K; von Deimling A; Van Dorpe J; Flucke U
    Mod Pathol; 2021 Nov; 34(11):2043-2049. PubMed ID: 34168281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benign recurring lipoblastoma in an adult versus well differentiated subcutaneous myxoid liposarcoma: clinicopathologic, immunohistochemical and molecular analysis of a unique case.
    Silverman JS; Hamilton J; Tamsen A
    Pathol Res Pract; 1999; 195(11):787-92; discussion 793. PubMed ID: 10605700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.
    Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F
    Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms.
    Downs-Kelly E; Goldblum JR; Patel RM; Weiss SW; Folpe AL; Mertens F; Hartke M; Tubbs RR; Skacel M
    Am J Surg Pathol; 2008 Jan; 32(1):8-13. PubMed ID: 18162764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Well-differentiated and dedifferentiated liposarcomas with prominent myxoid stroma: analysis of 56 cases.
    Sioletic S; Dal Cin P; Fletcher CD; Hornick JL
    Histopathology; 2013 Jan; 62(2):287-93. PubMed ID: 23020289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myxoid liposarcoma with cartilaginous differentiation: identification of the same type II TLS-CHOP fusion gene transcript in both lipogenic and chondroid components.
    Wei YC; Li CF; Eng HL; Yeh MC; Lin CN; Huang HY
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):477-80. PubMed ID: 18091394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysplastic Lipoma: A Distinctive Atypical Lipomatous Neoplasm With Anisocytosis, Focal Nuclear Atypia, p53 Overexpression, and a Lack of MDM2 Gene Amplification by FISH; A Report of 66 Cases Demonstrating Occasional Multifocality and a Rare Association With Retinoblastoma.
    Michal M; Agaimy A; Contreras AL; Svajdler M; Kazakov DV; Steiner P; Grossmann P; Martinek P; Hadravsky L; Michalova K; Svajdler P; Szep Z; Michal M; Fetsch JF
    Am J Surg Pathol; 2018 Nov; 42(11):1530-1540. PubMed ID: 30001242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.